Skip to main content
    V

    Vir Biotechnology Inc (VIR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.58
    -0.38 (-3.82%)

    Market Cap: $1.71B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vir Biotechnology Inc (VIR) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Net federal contract obligations to Vir Biotechnology were -$8.36M over the 12 months through Jul 31, 2026, as agencies removed more from existing contracts than they added. Vir Biotechnology had obligation activity on 1 federal contract over the same 12 months. Agencies report contract actions with a delay, so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    -$8.36M
    Obligations to revenue
    -12.8%
    Prior 12 months-$42.07M
    Contracts with activity1
    New contracts0

    12 months through Jul 31, 2026

    Monthly Obligations

    The latest complete month, Apr 2026, had no net obligations.

    MonthObligations
    Jul 2026$0
    Jun 2026$0
    May 2026$0
    Apr 2026$0
    Mar 2026$0
    Feb 2026$0
    Jan 2026$0
    Dec 2025$0
    Nov 2025$0
    Oct 2025$0
    Sep 2025$0
    Aug 2025-$8.36M
    MonthObligations
    Jul 2025$0
    Jun 2025$0
    May 2025$0
    Apr 2025$0
    Mar 2025$0
    Feb 2025$0
    Jan 2025$0
    Dec 2024$0
    Nov 2024$0
    Oct 2024$0
    Sep 2024-$42.07M
    Aug 2024$0

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About VIR

    How much does Vir Biotechnology receive in federal contracts?

    Vir Biotechnology had -$8.36M in federal contract obligations over the 12 months through Jul 31, 2026, compared with -$42.07M in the 12 months before. These were net de-obligations: agencies removed more from existing contracts than they added. Obligations are contract bookings by the awarding agency, not recognized revenue.

    How do Vir Biotechnology's federal obligations compare with its revenue?

    Federal contract obligations were -$8.36M over the 12 months through Jul 31, 2026, equivalent to -12.8% of Vir Biotechnology's revenue. Obligations are amounts the government committed to contracts in the period, not the share of Vir Biotechnology's revenue that comes from the government.